4351 - 4400 of 9148 Results
Title
Year
-
OPENTitle: Isocitrate dehydrogenase 1 is downregulated during early skin tumorigenesis which can be inhibited by overexpression of manganese superoxide dismutaseJournal Name: Cancer SciencePublisher: WileyVol: 103Issue #: 8Start Page: 1429End Page: 1433Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1349-7006.2012.02317.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2012.02317.xCitation Count: 20
-
OPENTitle: Modulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson’s DiseaseJournal Name: Frontiers in PhysiologyPublisher: Frontiers Media SAVol: 3Issue #:Start Page: 171End Page: 171Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphys.2012.00171Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphys.2012.00171/pdfCitation Count: 24
- Late Breaking News2025OPENTitle: Late Breaking NewsJournal Name: European Journal of NeurologyPublisher: WileyVol: 32Issue #: S1Start Page: e70263End Page: e70263Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.70263Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.70263Citation Count: 0
- ePresentation2025OPENTitle: ePresentationJournal Name: European Journal of NeurologyPublisher: WileyVol: 32Issue #: S1Start Page: e70191End Page: e70191Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.70191Best OA location URL: https://doi.org/10.1111/ene.70191Citation Count: 0
-
OPENTitle: Imaging of microglia in patients with neurodegenerative disordersJournal Name: Frontiers in PharmacologyPublisher: Frontiers Media SAVol: 3Issue #:Start Page: 96End Page: 96Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphar.2012.00096Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/389ab5ad-f662-40b8-981e-c6f04a287c58Citation Count: 114
-
OPENTitle: Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 748End Page: 759Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30140-1Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/113416685/MainText_Politis_RevisedManuscript_Clean.pdfCitation Count: 100
- An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural Networks2024RESTRICTEDTitle: An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural NetworksJournal Name: Digital Signal ProcessingPublisher: Elsevier BVVol: 147Issue #:Start Page: 104407End Page: 104407Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.dsp.2024.104407Citation Count: 25
- Self-reported physical activity levels and clinical progression in early Parkinson's disease2018RESTRICTEDTitle: Self-reported physical activity levels and clinical progression in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 61Issue #:Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.006Citation Count: 85
- Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease2024RESTRICTEDTitle: Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s DiseaseJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 20Issue #: 1Start Page: 137End Page: 152Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschembio.4c00602Citation Count: 2
-
OPENTitle: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 8Start Page: 3258End Page: 3272Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awad072Best OA location URL: https://academic.oup.com/brain/article-pdf/146/8/3258/51018455/awad072.pdfCitation Count: 127
-
OPENTitle: Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonismJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-026-03716-3Best OA location URL: https://doi.org/10.1186/s12974-026-03716-3Citation Count: 3
-
OPENTitle: Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal TinnitusJournal Name: BioMed Research InternationalPublisher: WileyVol: 2015Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2015/569052Best OA location URL: https://downloads.hindawi.com/journals/bmri/2015/569052.pdfCitation Count: 26
- Machine learning methods for optimal prediction of motor outcome in Parkinson’s disease2020RESTRICTEDTitle: Machine learning methods for optimal prediction of motor outcome in Parkinson’s diseaseJournal Name: Physica MedicaPublisher: Elsevier BVVol: 69Issue #:Start Page: 233End Page: 240Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmp.2019.12.022Citation Count: 55
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 12
- Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)2018OPENTitle: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 9Start Page: 793End Page: 802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nly056Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/9/793/25507335/nly056.pdfCitation Count: 37
-
OPENTitle: Rapid 2D 23Na MRI of the calf using a denoising convolutional neural networkJournal Name: Magnetic Resonance ImagingPublisher: Elsevier BVVol: 110Issue #:Start Page: 184End Page: 194Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mri.2024.04.027Best OA location URL: https://doi.org/10.1016/j.mri.2024.04.027Citation Count: 5
- Study of functional connectivity of central motor system in Parkinson’s disease using copula theory2020RESTRICTEDTitle: Study of functional connectivity of central motor system in Parkinson’s disease using copula theoryJournal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 65Issue #:Start Page: 102320End Page: 102320Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bspc.2020.102320Citation Count: 17
- Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia2013RESTRICTEDTitle: Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesiaJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 77Issue #: 4Start Page: 242End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neures.2013.10.002Citation Count: 47
- Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational study2012RESTRICTEDTitle: Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 10Start Page: 1084End Page: 1088Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.007Citation Count: 95
-
OPENTitle: The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1Journal Name: ChemBioChemPublisher: WileyVol: 19Issue #: 5Start Page: 425End Page: 429Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/cbic.201700500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cbic.201700500Citation Count: 63
- Concerns with the new biological research criteria for synucleinopathy – Authors' reply2024RESTRICTEDTitle: Concerns with the new biological research criteria for synucleinopathy – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 7Start Page: 663End Page: 666Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00233-3Citation Count: 5
- Disease-modifying therapies for Parkinson's disease2013OPENTitle: Disease-modifying therapies for Parkinson's diseaseJournal Name: The Biomedical & Life Sciences CollectionPublisher: Henry Stewart TalksVol: 2013Issue #: 3Start Page: e1003178End Page: e1003178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.69645/krxj9755Citation Count: 0
-
OPENTitle: The “Michael Foundation”—A foundation against epilepsyJournal Name: EpilepsiaPublisher: WileyVol: 55Issue #: 6Start Page: 803End Page: 805Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/epi.12509Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12509Citation Count: 0
- Fox Trial Finder, un nouvel outil pour la recherche clinique2014RESTRICTEDTitle: Fox Trial Finder, un nouvel outil pour la recherche cliniqueJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 170Issue #:Start Page: A133End Page: A134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360Citation Count: 0
- Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)2019RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-011Citation Count: 0
- Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)2019RESTRICTEDTitle: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-001Citation Count: 0
-
OPENTitle: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 7Start Page: 879End Page: 880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7533975Citation Count: 0
-
OPENTitle: 4319 Team Science in Parkinson’s Research: Connecting Clinicians and Computational TeamsJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 4Issue #: s1Start Page: 118End Page: 119Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.359Citation Count: 0
- Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)2017RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007Citation Count: 0
-
OPENTitle: Screening peripheral biopsies for alpha‐synuclein pathology using deep machine learningJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.047358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.047358Citation Count: 0
- O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH2018RESTRICTEDTitle: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACHJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 7S_Part_11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691Citation Count: 0
-
OPENTitle: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience DataJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 2Start Page: e28End Page: e29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088Best OA location URL: https://doaj.org/article/33431349c85d454db7ad2af33222a015Citation Count: 0
- No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)2013RESTRICTEDTitle: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187Citation Count: 0
-
OPENTitle: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemicJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049755Best OA location URL: https://doi.org/10.1242/dmm.049755Citation Count: 0
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities2021RESTRICTEDTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #: Autumn 123Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.36866/123.32Citation Count: 0
- A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)2018RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 10_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016Citation Count: 0
-
OPENTitle: Creating a patient‐centered guide to navigating cognitive change in Parkinson’s diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.041115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.041115Citation Count: 0
- P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers2012RESTRICTEDTitle: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296Citation Count: 0
-
OPENTitle: 0908 Multi-modal Recruitment of Individuals with REM Sleep Behavior Disorder into a Longitudinal Prodromal Parkinson’s StudyJournal Name: SLEEPPublisher: Oxford University Press (OUP)Vol: 46Issue #: Supplement_1Start Page: A400End Page: A400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsad077.0908Best OA location URL: https://academic.oup.com/sleep/article-pdf/46/Supplement_1/A400/50468111/zsad077.0908.pdfCitation Count: 0
- Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)2019RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
- Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)2017RESTRICTEDTitle: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002Citation Count: 0
- Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)2019RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
-
OPENTitle: 6 Association Between American Football Play and Parkinson's Disease: Analysis of the Fox Insight Data SetJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 29Issue #: s1Start Page: 415End Page: 416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617723005507Citation Count: 0
- Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)2017RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0
- Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)2019RESTRICTEDTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006Citation Count: 0
- Carepartner Communication on Parkinson Disease Psychosis (4116)2020RESTRICTEDTitle: Carepartner Communication on Parkinson Disease Psychosis (4116)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116Citation Count: 0
- Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)2020RESTRICTEDTitle: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402Citation Count: 0
- If You Don’t Ask, You Won’t Know: Inclusive Recruitment Strategies for the Parkinson Progression Markers Initiative (PPMI)2024RESTRICTEDTitle: If You Don’t Ask, You Won’t Know: Inclusive Recruitment Strategies for the Parkinson Progression Markers Initiative (PPMI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 122Issue #:Start Page: 106689End Page: 106689Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106689Citation Count: 0
- Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial results2025RESTRICTEDTitle: Falls during a remote observational Parkinson's disease study: AT-HOME PD2 initial resultsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 134Issue #:Start Page: 107560End Page: 107560Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107560Citation Count: 0